Xebra Brands Ltd. (XBRA.CN)
CAD 0.06
(-15.38%)
CAD 0.06
(-15.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.49 Million CAD | 49.5% |
| 2022 | -2.82 Million CAD | -4.08% |
| 2021 | -3.92 Million CAD | -122.19% |
| 2020 | -1.28 Million CAD | 15.7% |
| 2019 | -2.77 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -453.24 Thousand CAD | -11.19% |
| 2024 Q2 | -383.72 Thousand CAD | 25.8% |
| 2023 FY | - CAD | 49.5% |
| 2023 Q3 | -281.81 Thousand CAD | 20.97% |
| 2023 Q2 | -356.6 Thousand CAD | 20.6% |
| 2023 Q1 | -449.12 Thousand CAD | 24.96% |
| 2023 Q4 | -407.62 Thousand CAD | -44.64% |
| 2022 Q2 | -799.16 Thousand CAD | 12.65% |
| 2022 FY | - CAD | -4.08% |
| 2022 Q4 | -598.49 Thousand CAD | 7.61% |
| 2022 Q3 | -647.8 Thousand CAD | 18.94% |
| 2022 Q1 | -914.86 Thousand CAD | 26.32% |
| 2021 Q2 | -224.09 Thousand CAD | -9.38% |
| 2021 Q1 | -204.87 Thousand CAD | -72.17% |
| 2021 Q4 | -1.24 Million CAD | 12.91% |
| 2021 FY | - CAD | -122.19% |
| 2021 Q3 | -1.42 Million CAD | -536.2% |
| 2020 FY | - CAD | 15.7% |
| 2020 Q1 | -555.79 Thousand CAD | 0.0% |
| 2020 Q3 | -246.27 Thousand CAD | 25.83% |
| 2020 Q4 | -118.99 Thousand CAD | 51.68% |
| 2020 Q2 | -332.06 Thousand CAD | 40.25% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 75.386% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 25.64% |
| Blueberries Medical Corp. | -1.22 Million CAD | -22.361% |
| The BC Bud Corporation | -1.19 Million CAD | -24.998% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 76.945% |
| CordovaCann Corp. | -1.6 Million CAD | 6.715% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 43.014% |
| Captor Capital Corp. | 2.42 Million CAD | 161.747% |
| City View Green Holdings Inc. | -2.01 Million CAD | 25.787% |
| 1CM Inc. | 1.31 Million CAD | 213.815% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -5929.912% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 32.304% |
| IM Cannabis Corp. | -2.79 Million CAD | 46.416% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 66.04% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -281.167% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 53.179% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 230.956% |
| Ovation Science Inc. | -778.83 Thousand CAD | -91.954% |
| Pharmadrug Inc. | -1.33 Million CAD | -11.984% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 75.314% |
| RAMM Pharma Corp. | -6.3 Million CAD | 76.278% |
| RIV Capital Inc. | -20.28 Million CAD | 92.628% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 73.28% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 98.073% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 49.334% |
| 1933 Industries Inc. | -10.03 Million CAD | 85.099% |
| Red Light Holland Corp. | -5.25 Million CAD | 71.556% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -94.663% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -5.933% |